Jilin Aodong's controlling shareholder renews acting-in-concert agreement

Jilin Aodong Pharmaceutical Group Co., Ltd. announced on December 21, 2025, that its actual controller, Li Xiulin, and other parties have renewed their acting-in-concert agreement. This renewal extends the agreement, originally signed on December 21, 2020, for another five years from its effective date. The parties, including Dunhua Jinyuan Investment Co., Ltd. and four other shareholders of Dunhua Jincheng Industry Co., Ltd., will continue to act in concert, indirectly controlling the company through Jincheng Industry Co., Ltd.

Dunhua Jincheng Industry Co., Ltd. currently holds 327,080,749 shares of Jilin Aodong, representing 27.35% of the total share capital. The renewed agreement solidifies the control structure, with Li Xiulin and the other specified shareholders collectively owning 47,760,300 yuan of capital in Jincheng Industry Co., Ltd., which accounts for 91.19% of its registered capital.

Under the agreement, all parties will continue to act in unison when exercising shareholder rights in Jincheng Industry Co., Ltd., including proposal and voting rights. Li Xiulin is authorized to act on behalf of the parties, ensuring a unified approach to governance. The agreement also stipulates commitments regarding equity transfers and adherence to the agreement even if equity holdings change.